Virtual CISO for Healthtech

Healthtech companies carry a security burden most startups never face. You are handling protected health information, answering security questionnaires from hospital systems and insurers, and trying to close enterprise deals while your engineering team is still five people deep in product work. Nobody on staff owns security full-time, and the buyers on the other side of your sales calls know it. That gap is exactly what a fractional or virtual CISO is built to close.

Why healthtech is a different animal

Most SaaS companies can get away with a lightweight security posture for a while. Healthtech cannot. The moment you touch patient data, you are subject to a stack of obligations that do not care how big your team is: PHIPA in Ontario, PIPEDA at the federal level, HIPAA if you have US patients or covered-entity customers, and increasingly SOC 2 as a baseline expectation from any hospital network, insurer, or health system procurement office. Add device and interoperability standards if you touch clinical workflows, and the compliance surface gets wide fast.

The stakes are also different in kind, not just degree. A breach at a typical B2B SaaS company is a bad quarter. A breach involving patient health records is a regulatory investigation, a breach notification obligation, and a trust problem with every clinical partner you have. Healthtech buyers know this, which is why their security questionnaires are longer, their audits are stricter, and their sales cycles stall hard the moment your team cannot answer a security question with confidence.

The gap a virtual CISO fills

Most healthtech companies in growth stage do not need, and cannot afford, a full-time Chief Information Security Officer. That role commands a senior salary and, on its own, does not have enough day-to-day work to justify the cost at a 20 or 50 person company. But you still need someone who owns the security program end to end: someone accountable for risk decisions, someone who can sit across from a hospital IT director and speak the same language, someone who signs off on the board report.

That is the role our fractional CISO service is built to fill. Instead of hiring a full-time executive, you get a security leader on a fractional basis who owns your security program, runs point on customer security questionnaires, and reports to your board or investors on risk posture the way a full-time CISO would, at a cost and time commitment that fits a growth-stage healthtech budget.

What the role actually covers in healthtech

For healthtech clients specifically, the virtual CISO engagement tends to centre on a few recurring pressures:

• Security questionnaires from health systems and payers. These are longer and more specific than a typical enterprise SaaS questionnaire, often asking about encryption at rest and in transit, breach notification timelines, subprocessor management, and business associate agreement terms. Someone needs to own the answers and keep them consistent deal after deal.
• PHIPA and HIPAA alignment. Not a one-time checklist item, an ongoing program: access controls tied to minimum necessary use, audit logging on PHI access, incident response procedures that meet notification deadlines, and vendor management for every subprocessor that touches patient data.
• Board and investor reporting. Healthtech boards, especially once a health system or strategic investor is involved, expect regular risk reporting in plain language, not a raw vulnerability scan dump. A virtual CISO builds that reporting cadence and owns the narrative.
• SOC 2 as the enterprise gate. Increasingly, even clinical buyers ask for a SOC 2 report before they will move past procurement. A virtual CISO scopes the audit, prioritizes the controls that matter most for a healthtech risk profile, and keeps the program running after the report is issued rather than letting it decay.

How traztech scopes a healthtech engagement

We start with a short discovery pass: what data you handle, what regulatory frameworks actually apply to your business (not every healthtech company needs the full HIPAA stack, and we will tell you if you do not), what your current security posture looks like, and what your sales team is losing deals over. From there we scope the engagement around outcomes, not hours: a defined set of deliverables like a risk register, an incident response plan, a questionnaire response library, and a board reporting cadence, with clear milestones rather than an open-ended retainer.

Because the engagement is led by a published security researcher with real vulnerability disclosure experience, the guidance you get is grounded in how attackers actually operate, not just checkbox compliance. That matters more in healthtech than almost anywhere else, since patient data is a persistent, high-value target and a compliance certificate alone does not stop a competent attacker.

If your healthtech company is also working through a broader certification push, our compliance services pair naturally with the virtual CISO engagement, giving you one team that owns both the strategic security leadership and the audit-ready documentation work underneath it.

When to bring in a virtual CISO

The most common trigger we see is a stalled enterprise deal: a hospital system, insurer, or large clinical partner sends over a security questionnaire or asks for a SOC 2 report, and the founder realizes nobody internally can own that conversation credibly. The second most common trigger is growth itself, once you cross roughly 20 to 30 employees and start handling PHI at scale, ad hoc security ownership stops working and something has to give. Either way, the earlier you bring in dedicated security leadership, the less expensive the fix. Retrofitting a security program after a near-miss or a failed audit costs more, in both time and deal risk, than building it in from the start.

If your healthtech company needs a security leader who understands both the regulatory landscape and how real attackers think, get in touch and we will walk through what a virtual CISO engagement would look like for your stage and your data footprint.

What the first ninety days should actually produce

Healthtech founders often buy a fractional CISO and then find themselves three months in with a nicer-looking risk register and no change in how sales conversations go. The way to avoid that is to agree, in writing, what exists at day 30, day 60 and day 90, and to make those artifacts the ones your buyers ask for rather than the ones a framework template suggests.

By day 30 you should have a data map that a clinical buyer would accept: every system that stores or transmits PHI, who the custodian is, where it physically sits, and which subprocessor touches it. Most healthtech companies discover something uncomfortable during this exercise, usually a support tool holding attachments with patient identifiers, or a data warehouse containing a copy of production that nobody scoped as PHI. Finding that in month one is worth the engagement fee on its own.

By day 60 you should have a completed baseline against whichever framework is driving the work, an incident response plan with named roles and the actual notification clocks written into it, and a first pass at a questionnaire response library built from the last dozen questionnaires you received. By day 90 you should have a board-ready risk report, an access review that has actually been run once rather than documented as a policy, and a remediation roadmap with owners and dates that your engineering lead has agreed to rather than been handed.

If a prospective vCISO cannot describe deliverables at that level of specificity before you sign, that is the moment to keep looking.

The business associate agreement is where the real obligations hide

Every healthtech company signs BAAs, and very few read them past the signature block. A vCISO earns their fee in this document more than almost anywhere else, because the terms you accept here become operational requirements your engineering team has to meet for years.

Watch three clauses in particular. The breach notification window is often negotiated down from the statutory position to something like twenty-four or forty-eight hours from discovery, and sometimes to notification of any "security incident" rather than any breach, which if read literally means telling your customer about every blocked scan against your perimeter. Push to define security incident as an event with a reasonable likelihood of compromise, or you will either flood your customer with noise or quietly breach the agreement.

The second is subcontractor flow-down. You are obliged to bind every subprocessor touching PHI to terms at least as protective as the ones you signed. That means a signed BAA with your cloud provider, your logging vendor, your email provider, your transcription service, and any model API in the path. Missing BAAs is one of the most common findings we see, and it is usually not negligence, it is that the vendor list grew faster than anyone tracked.

The third is the return-or-destroy obligation at termination. Companies commit to destroying all PHI within thirty days of contract end, then discover their backup retention is set to a year and their disaster recovery copies are immutable by design. Reconcile the contractual promise with the technical reality before you sign, not when a customer offboards.

When a customer asks for HITRUST instead of SOC 2

Sooner or later a large health system or payer will ask for HITRUST, and the founder's instinct is to treat it as a slightly heavier SOC 2. It is not. HITRUST is a prescriptive certification with a defined control set scaled to your risk factors, assessed by an authorized external assessor, and it costs and takes substantially more than a SOC 2 Type II for a company of the same size.

The useful work here is not compliance, it is negotiation. In a large share of cases the buyer's requirement is satisfiable another way: a SOC 2 Type II with the confidentiality and privacy criteria added, a documented HIPAA Security Rule risk analysis, and a current penetration test will clear many procurement teams that opened with HITRUST as the default ask. Someone has to have that conversation with the buyer's security team credibly, and that is exactly the conversation a founder cannot have alone and a compliance platform cannot have at all.

Sometimes the answer is genuinely no, the customer's own policy requires certification and there is no path around it. Then the right advice is to price the certification honestly against the contract value and decide it as a commercial question. We have told healthtech companies that the deal in front of them did not justify the certification spend, and that the better move was to close three mid-market customers first on a SOC 2 and revisit in a year.

Minimum necessary and audit logging, in practice

Two requirements look simple on paper and consistently produce the most engineering work in a healthtech program.

Minimum necessary access means your support engineers should not be able to read every patient record by default. The common state at a growth-stage company is that a handful of internal roles have blanket read access to production because that is how debugging has always worked. The fix is not to revoke everything on a Friday. It is to introduce a break-glass path: time-limited elevation, tied to a ticket, logged with a reason, reviewed weekly. Engineers accept this readily when the elevation takes fifteen seconds and does not require a manager to wake up. They route around it when it takes an hour.

Audit logging on PHI access means record-level logs of who viewed what and when, retained long enough to satisfy your obligations, and searchable well enough to answer a patient or regulator asking who accessed a specific record. Application-level logs of API calls are frequently not sufficient, because they show that an endpoint was hit rather than which records were returned. Getting this right is a schema and instrumentation decision, and it is far cheaper to make it before you have three years of data than after.

Model training and secondary use will get asked about

Healthtech companies increasingly want to use their data for analytics, benchmarking, or training a model. Your BAAs, your privacy notices and PHIPA all have opinions about that, and the gap between what the product team assumes and what the contracts permit is often wide.

The questions a vCISO should force before any of that work starts are whether the data is genuinely de-identified under the standard that applies to you, who validated that, and whether your agreements permit the secondary use at all. De-identification claims made by an engineer looking at a table with the name column dropped do not survive scrutiny, particularly with dates of service, postal codes and rare diagnoses in the same row. If the answer is that you need consent or a research agreement, better to learn it in a design review than in a customer audit.

Failure modes we see in fractional CISO engagements

The engagement fails in a small number of recognizable ways, and all of them are avoidable.

The name on the org chart. A company hires a vCISO purely so a questionnaire field has an answer, then never gives them access to systems, standups or the roadmap. Buyers detect this quickly, because they ask the security owner a question and get an answer that does not match what the engineering team says.

The generic operator. A vCISO with a strong enterprise IT background and no healthcare context will apply a corporate control catalog to a clinical product and produce recommendations that make no sense in a care workflow. Ask any candidate to describe a BAA negotiation they ran and how they handled a PHI access review. The answers separate people fast.

No engineering counterpart. The vCISO owns the program, but somebody inside the company has to own implementation. If nobody has time allocated for remediation work, the roadmap ages and every quarterly report says the same thing. Name that person before the engagement starts and give them explicit capacity.

Undefined incident authority. Decide up front whether the vCISO can declare an incident, engage counsel, and instruct engineering to take a system offline. At 2am, ambiguity is expensive. Put it in the agreement.

When you should not hire one

Skip it if you have not touched PHI yet. Pre-launch healthtech companies with a design partner and no production patient data are better served by spending the money on architecture decisions that avoid problems later, principally tenancy, encryption and access model. An hour of advisory input at that stage beats a monthly retainer with nothing to govern.

Skip it if your need is genuinely one framework, one time. If a single customer wants a SOC 2 Type I and your environment is small and modern, a fixed-scope readiness engagement is the cheaper and more honest purchase. Our published SOC 2 work starts at a $3,000 gap analysis for exactly this case, and a founder with an organized engineering team can carry a lot of it themselves using the free Workspace to keep evidence and policies in one place. A documented readiness position also tends to bring the audit quote itself down, because the auditor is pricing a known environment instead of an unknown one, and that saving arrives without any ongoing retainer attached to it.

Skip it if you already have a security-minded VP of Engineering with capacity and interest. Some do, and the honest recommendation in that case is periodic expert review rather than fractional leadership. Four sessions a year with someone who reads your risk register critically and challenges your assumptions costs a fraction of a retainer and is often enough until you cross fifty people or take on a hospital contract.

And skip the retainer if what you actually have is an unmanaged technical risk rather than a leadership gap. If nobody has ever tested your product from the outside, a penetration test tells you more about your real exposure than a quarter of governance work, and it costs less.

How the engagement should end

A fractional CISO relationship in healthtech usually has a natural end point, and a good one is designed for it. The trigger is normally headcount and contract scale: once you are running multiple health system contracts, a security team of two or three, and a continuous certification cycle, the work stops being fractional and a full-time hire becomes the better economics.

Ask at the start what the handover contains. It should include the risk register with history rather than a current snapshot, the policy set with revision records, the questionnaire response library, the auditor and assessor relationships with context on what each has flagged, and an honest written assessment of what is still broken. The last item is the one that distinguishes a real practitioner from a vendor protecting their renewal, and it is the reason our fractional CISO engagements are written to be exited cleanly rather than to be permanent.